ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,920.57
0.06%
US Tech 100
20,001.20
-0.62%
Dow Jones
43,565.45
0.36%
Brent Oil
73.635
1.09%
Bitcoin
97,044.26
2.85%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Germany
  5. TG

  6. 4 SC AG (VSC) Quote

4 SC AG

4 SC AG (VSC)

Vanguard Canadian Short Term Corporate Bond Index ETF
4.80
-0.46
( -8.75% )
Updated: 09:06:32
Realtime Data

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
4.80
Bid
4.62
Ask
5.00
Volume
4,019
4.50 Day's Range 4.99
3.99 52 Week Range 11.20
Market Cap
48.547M
Previous Close
5.26
Open
4.99
Last Trade
200
@
4.8
Last Trade Time
09:06:09
Financial Volume
-
VWAP
-
Average Volume (3m)
2,644
Shares Outstanding
10,114,009
Dividend Yield
-
PE Ratio
0.00
Earnings Per Share (EPS)
-
Revenue
304k
Net Profit
-8.24M

About 4 SC AG

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.4sc.com
Headquarters
Munich, Deu
Founded
-
4 SC AG is listed in the Pharmaceutical Preparations sector of the Tradegate (DE) with ticker VSC. The last closing price for 4 SC was 5.26 €. Over the last year, 4 SC shares have traded in a share price range of 3.99 € to 11.20 €.

4 SC currently has 10,114,009 shares outstanding. The market capitalization of 4 SC is 53.20 € million.

Ask ADVFN Intelligence (AI)

VSC Latest News

More News

4SC's Anti-Cancer Compound Resminostat Receives Positive Opinion for Orphan Medicinal Product Designation in Europe to Treat ...

4SC AG (Frankfurt, Prime Standard: VSC), a discovery and development company of targeted small molecule drugs for autoimmune diseases and cancer, today announced that the...

October 13 2011
Business Wire

4SC's Resminostat receives FDA Orphan Drug Status for Hodgkin's Lymphoma

4SC AG (Frankfurt, Prime Standard: VSC), a discovery and development company of targeted small molecule drugs for autoimmune diseases and cancer, today announced that the US...

September 26 2011
Business Wire

European Medicines Agency Adopts Positive Opinion for Orphan Medicinal Product Designation for 4SC's Resminostat to Treat Hep...

4SC AG (Frankfurt, Prime Standard: VSC), a discovery and development company of targeted small molecule drugs for autoimmune diseases and cancer, today announced that the...

July 26 2011
Business Wire

FDA Grants Orphan Drug Designation to 4SC's Oral Pan-HDAC Inhibitor Resminostat for the Treatment of Hepatocellular Carcinoma

4SC AG (FWB:VSC), a discovery and development company of targeted small molecule drugs for autoimmune diseases and cancer, today announced that the US Food and Drug...

July 12 2011
Business Wire

4SC Announces Topline Results of Phase IIb Trial of Vidofludimus in Rheumatoid Arthritis

4SC AG (Frankfurt, Prime Standard: VSC), a discovery and development company of targeted small molecule drugs for autoimmune diseases and cancer, today announced topline results...

June 08 2011
Business Wire

EULAR 2011 - Vidofludimus Superior to Cyclophosphamide and MMF in an Experimental Systemic Lupus Erythematosus Model

4SC AG (Frankfurt, Prime Standard: VSC), a discovery and development company of targeted small molecule drugs for autoimmune and cancer diseases, will present pre-clinical data...

May 27 2011
Business Wire

4SC's Vidofludimus Inhibits IL-17 Production by Interference With the JAK/STAT and NF-B Pathways

4SC AG (Frankfurt, Prime Standard: VSC), a drug discovery and development company focused on autoimmune and cancer indications, has presented novel data on the mechanism of...

May 09 2011
Business Wire

4SC and Yakult Honsha Announce Exclusive License Agreement for Japan for the Oral HDAC Inhibitor Resminostat

4SC AG (Frankfurt, Prime Standard: VSC) and Yakult Honsha Co.; Ltd. (Tokyo: 2267) today announced the grant of an exclusive license by 4SC to Yakult Honsha for the development...

April 14 2011
Business Wire

4SC Announces Treatment of First Patient in Phase I TOPAS Study with the selective HDAC inhibitor 4SC-202

4SC (Frankfurt, Prime Standard: VSC), a drug discovery and development company, today announced that the first patient has been treated in the Phase I TOPAS study with 4SC-202...

April 13 2011
Business Wire

4SC Announces Financial Results 2010

4SC AG (Frankfurt, Prime Standard: VSC), a drug discovery and development company focused on autoimmune and cancer indications, today announced its financial results in...

March 29 2011
Business Wire
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.72-13.04347826095.525.984.510555.30477436DE
4-1.34-21.82410423456.146.524.58575.67778141DE
12-0.03-0.6211180124224.839.54.526446.3357306DE
26-3.18-39.84962406027.989.53.9921326.14364649DE
52-2.95-38.0645161297.7511.23.9922417.54414835DE
1560.2154.689203925854.58511.21.1725705.04945647DE
2602.84144.8979591841.9611.21.0567712.53460641DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
0S6Cerence Inc
4.8115 €
(79.47%)
14.48k
5Q5Snowflake Inc
160.34 €
(30.78%)
58.67k
ZK7Conduit Pharmaceuticals Inc
0.112 €
(28.00%)
120.73k
5ZOLiMetal Corp
0.0514 €
(20.66%)
325
5EROrigin Materials Inc
1.1605 €
(18.15%)
12.5k
BVU3St James Gold Corp
0.048 €
(-54.72%)
250
AAJ0Perspective Therapeutics Inc
3.24 €
(-44.62%)
560
KURKura Oncology Inc
9.624 €
(-36.22%)
7.05k
85G1StGeorges EcoMining Corp
0.024 €
(-33.33%)
12k
YP2ABioline Rx Ltd
0.356 €
(-31.54%)
50.72k
D7GNel ASA
0.2512 €
(-7.61%)
14.43M
P1MPeninsula Energy Limited
0.0343 €
(-7.05%)
2.05M
GHUADX Energy Ltd
0.0318 €
(-21.29%)
1.88M
NVDNVIDIA Corp
137.64 €
(-0.59%)
1.11M
AUBLepidico Ltd
0.0012 €
(-25.01%)
1.1M

Discussion

View Full Feed
Timing101 Timing101 1 minute ago
Well , some volume today , but in the RED. MG will probably say again, someone had to pay their taxes
DUTV
RobotDroid RobotDroid 1 minute ago
Sorry for your pending loss.
NWBO
ducci1 ducci1 1 minute ago
Back in 593C .48? Bought the Dip?
SPY
runncoach runncoach 1 minute ago
Read my previous posts over the years for substance. They all fail to meet robust expectations. It's the nature of the beast. I give these guys as good a shot as any...which is a long shot IMO
SAVA
jobynimble jobynimble 2 minutes ago
Finally getting some volume in Canada…
SPAIF
ITYS ITYS 2 minutes ago
Tech, thanks brother, hey saw shondale in here, little weasel curled up in corner LOL
TOO funny how both GEVI, MWWC turned out to be scams as we stated.

GEVI, the idiot steal posting videos from last November, Their subsequent events tells the truth..all they can do is dump PFD
GEVI MWWC
Alpha14 Alpha14 2 minutes ago
Thank you for the update.
RNVA
Tiger Money Tiger Money 2 minutes ago
Below 9 cents.  Here comes a nickel and then the bad news.  Stinky pinkies are like clockwork.  If I could short this thing I would!
RDGL
PonkenPlonken PonkenPlonken 2 minutes ago
BFLY dip
BYRN
BFLY
RobotDroid RobotDroid 2 minutes ago
He plays a doctor in his mind only.
NWBO
dreamaker56 dreamaker56 2 minutes ago
Oh I 100% agree, but why not let it just sink away into the abyss? Why keep current?
BLDV
cableguy cableguy 3 minutes ago
They don't have that anymore they changed it to OTCQB. Thats for sure why were here, LoL.. VHAI

https://www.investopedia.com/terms/o/otcqx.asp

Key Takeaway
The OTCQX is the highest quality tier of OTC markets and offers trading in companies that are not listed on
VHAI
mr34 mr34 3 minutes ago
Don’t worry it will be forgotten about just like the long list of everything else that was pumped and misguided, I am still waiting on the partnership with RTX LOL.
RTX
tw0122 tw0122 3 minutes ago
At .86 sold most see if $1 return comes 
DGLY
Moonboy1 Moonboy1 3 minutes ago
Did they open huntinf or what? haha. Consolidating above old high now for the next leg up in my opinion
QUBT
BIOChecker4 BIOChecker4 3 minutes ago
I agree slowness is an important issue but in my opinion the other, more important issue, is whether Missling is competent to execute effectively on behalf of shareholders. Based on his track record, I do think there is reason to be deeply concerned about his competency.
AVXL
Juschilln Juschilln 3 minutes ago
Buy set at $3.35, hoping for the best
CATX
TrendTrade2016 TrendTrade2016 3 minutes ago
BACK IN SPAI 4 BUCKS
SPAI
snow snow 3 minutes ago
LV You need to read my post at least once more. My post is just simple logic and numbers. I express no opinion on the value of this company. I just pinpoint the logical fallacies of the post I address.
HERB
lager lager 3 minutes ago
Yes they do and it shows. This is literally just a matter of time. I wish I had another million shares.
MGON
oldstocks oldstocks 3 minutes ago
PB DigiBriks SL merger

In April DigiBriks was in the beginning stages of putting a group of companies into DigiBriks SL

Now DigiBriks SL is closer to realty and closer to getting the merger completed.

That is my thought
AFFU
RobotDroid RobotDroid 4 minutes ago
100% correct.
NWBO
swingingRichard swingingRichard 4 minutes ago
KABOOOOOOOOMS Coming!!

I thought the SEC played investigations close to the vest.
AABB
MoneyMan MoneyMan 4 minutes ago
Where did that come from. Did she tweet that?
CEOS
Tiger Money Tiger Money 4 minutes ago
Thanks
CATX

Your Recent History

TG
VSC
4 SC
DOWI
DJBGIT
DJ Brookfield Global Inf...
COIN
POLUSD
POL (ex-MATIC)
LSE
TAVI
Tavistock Investments
LSE
AIBG
Aib
USOTC
AMIVF
Atruim Mtg Investment (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved